| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cardiovascular Diseases | |||||
| Cerebrovascular Disorders | |||||
| Heart Diseases | |||||
| Hypertension | |||||
| 2 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Nervous System Diseases | |||||
| Vascular Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| chlorthalidone | |||||
| atenolol | |||||
| reserpine | |||||
| 4 | More general drug interventions related to this trial | ||||
| Adrenergic Agents | |||||
| Adrenergic Uptake Inhibitors | |||||
| Antihypertensive Agents | |||||
| Antipsychotic Agents | |||||
| Cardiovascular Agents | |||||
| Central Nervous System Agents | |||||
| Central Nervous System Depressants | |||||
| Diuretics | |||||
| Membrane Transport Modulators | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Natriuretic Agents | |||||
| Neurotransmitter Agents | |||||
| Neurotransmitter Uptake Inhibitors | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Psychotropic Drugs | |||||
| Sodium Chloride Symporter Inhibitors | |||||
| Therapeutic Uses | |||||
| Tranquilizing Agents | |||||
| 5 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||
| National Institute on Aging (NIA) | |||||
|
